11 employees
Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.
2021
$2.6M
from 2 investors over 2 rounds
Rarity Bioscience raised $539K on February 6, 2023
Investors: Novalis_Fund
Rarity Bioscience raised $2.6M on November 29, 2022
Investors: Navigare Ventures